Synonyms: | |
Status: | Approved (2012) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | A08AA11 |
UNII: | 637E494O0Z |
InChI Key | XTTZERNUQAFMOF-QMMMGPOBSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C11H14ClN |
Molecular Weight | 195.69 |
AlogP | 2.59 |
Hydrogen Bond Acceptor | 1.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 0.0 |
Polar Surface Area | 12.03 |
Molecular species | BASE |
Aromatic Rings | 1.0 |
Heavy Atoms | 13.0 |
Primary Target | |
---|---|
5-HT2C receptor |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Serotonin receptor
|
2-210 | - | - | 15-257 | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC06 neurotransmitter transporter family
|
- | - | - | 2606 | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Obesity | 4 | D009765 | ClinicalTrials |
Opioid-Related Disorders | 2 | D009293 | ClinicalTrials |
Peripheral Nervous System Diseases | 2 | D010523 | ClinicalTrials |
Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
Tobacco Use Disorder | 2 | D014029 | ClinicalTrials |
Kidney Diseases | 1 | D007674 | ClinicalTrials |
Liver Diseases | 1 | D008107 | ClinicalTrials |
Substance-Related Disorders | 1 | D019966 | ClinicalTrials |
Marijuana Abuse | 1 | D002189 | ClinicalTrials |
Cardiovascular Diseases | 1 | D002318 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 616202-92-7 |
ChEBI | 65353 |
ChEMBL | CHEMBL360328 |
DrugBank | DB04871 |
DrugCentral | 4374 |
EPA CompTox | DTXSID3048659 |
FDA SRS | 637E494O0Z |
Guide to Pharmacology | 2941 |
PubChem | 11658860 |
SureChEMBL | SCHEMBL169382 |
ZINC | ZINC000006733300 |